Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

81.50
-1.4400-1.74%
Post-market: 81.500.00000.00%19:30 EDT
Volume:1.74M
Turnover:143.16M
Market Cap:15.96B
PE:-22.84
High:83.37
Open:82.89
Low:81.36
Close:82.94
52wk High:93.42
52wk Low:46.81
Shares:195.81M
Float Shares:154.00M
Volume Ratio:0.63
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-6.34
PE(LYR):-21.53

Loading ...

BridgeBio posts ESC-HF presentation on acoramidis impact on NT-proBNP in ATTR-CM

Reuters
·
May 11

BridgeBio publishes acoramidis-versus-tafamidis ATTR-CM analysis presentation

Reuters
·
May 11

BRIEF-Acoramidis Continues To Demonstrate Disease-Modifying Effects In ATTR-CM

Reuters
·
May 11

BridgeBio says acoramidis cuts outpatient worsening heart failure risk 41% in Phase 3 trial

Reuters
·
May 11

Acoramidis Continues to Demonstrate Disease-Modifying Effects in Attr-Cm, Reducing Sttr Variability and Outpatient Worsening Heart Failure

THOMSON REUTERS
·
May 11

BridgeBio Pharma Inc - Acoramidis Reduces Cardiovascular Hospitalizations by 34% Versus Tafamidis

THOMSON REUTERS
·
May 11

BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 11

BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $110 From $100

THOMSON REUTERS
·
May 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), BridgeBio Pharma (BBIO) and Globus Medical (GMED)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Gains And Recent Share Price Weakness

Simply Wall St.
·
May 11

BRIEF-Bridgebio Pharma reports inducement grants under Nasdaq listing rule 5635(C)(4)

Reuters
·
May 09

BridgeBio grants 115,007 restricted stock units to 52 new employees

Reuters
·
May 09

BridgeBio price target raised to $130 from $125 at Evercore ISI

TIPRANKS
·
May 09

BridgeBio price target lowered to $94 from $98 at Morgan Stanley

TIPRANKS
·
May 08

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 08

BridgeBio Pharma launches at-the-market equity program for up to $500 million

Reuters
·
May 08

RBC Capital Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
May 08

BridgeBio price target raised to $114 from $100 at Bernstein

TIPRANKS
·
May 08

BridgeBio files automatic mixed securities shelf

TIPRANKS
·
May 08